Clinical Efficacy and sAfety of Intravenous Infusion of Nicorandil During Primary Percutaneous Coronary Intervention
Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
The investigators evaluate the efficacy and safety of intravenous administration of
nicorandil as adjuncts to reperfusion treatment in acute ST-segment elevation acute
myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention
(PCI).